Preparing for a cell culturing industry

Anticipating new drug approvals that could show up as soon as 2017, the bioprocessing industry is gradually assembling the pieces that will, in fact, constitute a new form of pharmaceutical manufacturing: cell culturing, a.k.a. regenerative medicine, a.k.a. stem cell processing. […]

Read More

A conversation with Terry Hisey, Deloitte

  As one of the Big Four accounting and advisory firms, Deloitte deals with a large portion of the pharmaceutical industry, both domestically and internationally. In fact, the company says that it has not only the leading position with pharma, […]

Read More

HDMA is now the Healthcare Distribution Alliance

It might strike outsiders as a subtle—and minor—change in emphasis, but there are significant drivers behind the Healthcare Distribution Management Assn.’s rebranding as HDA. The organization has had major success in two pieces of recent federal legislation: the Drug Supply […]

Read More